Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Oncogene
|
May 26, 2010
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
K G Wiman
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 1, 1993
The retinoblastoma gene: role in cell cycle control and cell differentiation
K G Wiman
Cell Death and Differentiation
|
March 25, 2006
Strategies for therapeutic targeting of the p53 pathway in cancer
K G Wiman
Lakartidningen
|
February 12, 1998
[New transcription factor-based cancer therapy. Gene therapy, cell lysis, reactivation of p53 are the new approaches]
K G Wiman
Medical Oncology (Northwood, London, England)
|
February 10, 1999
New p53-based anti-cancer therapeutic strategies
K G Wiman
Lakartidningen
|
September 23, 1992
[Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors]
K G Wiman
Cell Death and Differentiation
|
October 8, 2013
p53 talks to PARP: the increasing complexity of p53-induced cell death
K G Wiman
Experimental Cell Research
|
January 7, 1998
p53: emergency brake and target for cancer therapy
K G Wiman
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
February 15, 2000
Polyoma virus middle T and small t antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis
W Qian, K G Wiman
Journal of Internal Medicine
|
April 21, 2017
Introduction to Nobel Conference: 'The Cell Cycle and Cell Death in Disease'
K G Wiman, B Zhivotovsky
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Oncogene
|
May 26, 2010
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
K G Wiman
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 1, 1993
The retinoblastoma gene: role in cell cycle control and cell differentiation
K G Wiman
Cell Death and Differentiation
|
March 25, 2006
Strategies for therapeutic targeting of the p53 pathway in cancer
K G Wiman
Lakartidningen
|
February 12, 1998
[New transcription factor-based cancer therapy. Gene therapy, cell lysis, reactivation of p53 are the new approaches]
K G Wiman
Medical Oncology (Northwood, London, England)
|
February 10, 1999
New p53-based anti-cancer therapeutic strategies
K G Wiman
Lakartidningen
|
September 23, 1992
[Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors]
K G Wiman
Cell Death and Differentiation
|
October 8, 2013
p53 talks to PARP: the increasing complexity of p53-induced cell death
K G Wiman
Experimental Cell Research
|
January 7, 1998
p53: emergency brake and target for cancer therapy
K G Wiman
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
February 15, 2000
Polyoma virus middle T and small t antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis
W Qian, K G Wiman
Journal of Internal Medicine
|
April 21, 2017
Introduction to Nobel Conference: 'The Cell Cycle and Cell Death in Disease'
K G Wiman, B Zhivotovsky
Page
of 9